10-Q Filing

CVS HEALTH CORP CIK: 64803 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0000064803-21-000017`
Period End Date	20210331
Filing Date	20210504
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	cvs-20210331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 100 Income Statement 40 Cash Flow Statement 74 Stockholders Equity 34 Comprehensive Income 16

Balance Sheet 100 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.60B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.85B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$3.00B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$3.19B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$23.86B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$21.74B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$17.62B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$18.50B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.46B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.28B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$55.72B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.74B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$56.37B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$20.81B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.31B	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$21.02B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.31B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.61B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.61B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	423.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	422.00M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.54B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.73B	USD	Point-in-time
Goodwill	`Goodwill`	$79.55B	USD	Point-in-time
Goodwill	`Goodwill`	$79.55B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$31.14B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$30.64B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.69B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.88B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.83B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.62B	USD	Point-in-time
Total assets	`Assets`	$229.61B	USD	Point-in-time
Total assets	`Assets`	$230.72B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$10.80B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$11.14B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$15.79B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$16.28B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$8.27B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$7.94B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$4.44B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$4.27B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$14.31B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$14.24B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.53B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.56B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.64B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.79B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$252.00M	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	-	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$2.42B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$5.44B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$60.10B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$62.02B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.76B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.59B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$59.21B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$59.27B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$6.61B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$6.79B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.88B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.69B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$6.87B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.01B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.31B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.35B	USD	Point-in-time
Total liabilities	`Liabilities`	$161.01B	USD	Point-in-time
Total liabilities	`Liabilities`	$158.44B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,735 shares issued and 1,313 shares outstanding at March 31, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$46.73B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,735 shares issued and 1,313 shares outstanding at March 31, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$46.51B	USD	Point-in-time
Treasury stock, at cost: 422 shares at March 31, 2021 and 423 shares at December 31, 2020	`TreasuryStockValue`	$28.18B	USD	Point-in-time
Treasury stock, at cost: 422 shares at March 31, 2021 and 423 shares at December 31, 2020	`TreasuryStockValue`	$28.10B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$51.20B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$49.64B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.41B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.02B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$70.85B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$69.39B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$314.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$312.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$229.61B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$230.72B	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$17.64B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$18.96B	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$297.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$162.00M	USD	1 Quarter
Total revenues	`Revenues`	$66.75B	USD	1 Quarter
Total revenues	`Revenues`	$69.10B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$40.89B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$40.35B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$14.39B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$15.70B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$8.92B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$8.56B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$65.52B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$63.30B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.46B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.58B	USD	1 Quarter
Interest expense	`InterestExpense`	$657.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$733.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$50.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$54.00M	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.97B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.78B	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$767.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$746.00M	USD	1 Quarter
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$2.22B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$2.01B	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.54	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.69	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.68	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.53	USD	1 Quarter
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.32B	shares	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$66.49B	USD	1 Quarter
Cash receipts from customers	`ProceedsFromCustomers`	$63.75B	USD	1 Quarter
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$36.97B	USD	1 Quarter
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$39.17B	USD	1 Quarter
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$14.30B	USD	1 Quarter
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$15.46B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$8.27B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$8.19B	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$206.00M	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$222.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$1.13B	USD	1 Quarter
Interest paid	`InterestPaidNet`	$876.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$44.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$65.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.89B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.31B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.18B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.29B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$1.53B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$3.13B	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$742.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$829.00M	USD	1 Quarter
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$613.00M	USD	1 Quarter
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$84.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-5.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.87B	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.60B	USD	1 Quarter
Net borrowings of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$252.00M	USD	1 Quarter
Net borrowings of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$255.00M	USD	1 Quarter
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	1 Quarter
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.95B	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.01B	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$3.05B	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$652.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$656.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$212.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$154.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$3.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$16.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-4.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.67B	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.24B	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.22B	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.38B	USD	1 Quarter
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.91B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.34B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.91B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.34B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.13B	USD	Point-in-time
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.09B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.13B	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$96.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$87.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-166.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-35.00M	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.09B	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.71B	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-541.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-879.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$223.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.12B	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$576.00M	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.93B	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$294.00M	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$139.00M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$188.00M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.37B	USD	1 Quarter

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Decrease in retained earnings	`RetainedEarningsAccumulatedDeficit`	$51.20B	USD	Point-in-time
Decrease in retained earnings	`RetainedEarningsAccumulatedDeficit`	$49.64B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-332.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-392.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$214.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$208.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$53.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$76.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$660.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$657.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$23.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$1.00M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Net unrealized investment losses	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-386.00M	USD	1 Quarter
Net unrealized investment losses	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-311.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-12.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-9.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-332.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-392.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.83B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.68B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.68B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.83B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.